1
Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC
Condition(s):Non-small Cell Lung Cancer Stage IIILast Updated:February 21, 2021Not yet recruiting
Concurrent Immuno-chemotherapy: 6 Clinical Trials
Hide Studies Not Open or Pending
2
Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)
Condition(s):T-cell-prolymphocytic LeukemiaLast Updated:May 11, 2018Completed
3
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
Condition(s):Cutaneous T-cell LymphomaLast Updated:December 24, 2018Terminated
4
Anti-PD-L1 and SAbR for Ovarian Cancer
Condition(s):Recurrent Epithelial Cancer of Ovary; Primary Peritoneal Carcinoma; Fallopian Tube CancerLast Updated:November 12, 2020Terminated
5
A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Condition(s):Lymphoma, AIDS Related; HIV InfectionsLast Updated:September 12, 2013Completed
6
Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
Condition(s):Malignant MelanomaLast Updated:October 25, 2016Unknown status